Health Condition 1: E11- Type 2 diabetes mellitus
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Dr Parv Mathur
Eligibility
Inclusion criteria
Inclusion criteria: Age greater than or equal to 18 years Males and females T2DM patients starting semaglutide or tirzepatide as add on therapy for the first time at the time of screening Body Mass Index greater than or equal to 23 Kg per m2 Patients who had previously been on antidiabetic drugs for at least 6 months Willing and able to undergo treatment and follow-up as required by the protocol.
Exclusion criteria
Exclusion criteria: Any known significant gastric emptying and severe gastrointestinal diseases at screening Female who is pregnant or intends to become pregnant during the study period, or is lactating at the time of screening
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of semaglutide and tirzepatide as add-on therapy in HbA1c reduction and reduction in body weight To assess the safety of semaglutide and tirzepatideTimepoint: Assessment at baseline, 1 month, 3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Anuradha HV
MS Ramaiah Medical College, Bengaluru
Outcome results
None listed